Abbott aspires to be a leader in development of "future-ready" cardiac rhythm management (CRM) devices that do not need to be frequently replaced or explanted.
Late last year, Medtech Insight talked to Leonard Ganz, Abbott’s CRM business as its divisional vice president of medical affairs and chief medical officer, to talk about the company's development of leadless CRM devices, including Aveir VR, the only leadless pacemaker with unique mapping capabilities that can be easily retrieved as the patient's need for new therapies change